Mirum Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.026; its P/E ratio is -5.94; Mirum Pharmaceuticals is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 69.55M	$ 47.73M	$ 32.50M	$ 29.10M	-
Gross Profit	$ 69.55M	$ 47.73M	-	-	-
EBIT	$ -35.43M	$ -23.34M	$ -73.72M	$ -25.69M	-
EBITDA	$ -29.57M	-	$ -72.86M	$ -25.04M	-
Net Income Common Stockholders	$ 25.58M	$ -47.28M	$ -74.04M	$ -61.73M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 286.33M	$ 306.03M	$ 329.95M	$ 132.07M	$ 151.72M
Total Assets	$ 646.62M	$ 650.64M	$ 443.57M	$ 332.67M	$ 351.96M
Total Debt	$ 308.14M	$ 307.97M	$ 307.83M	$ 1.97M	$ 2.19M
Net Debt	$ 21.82M	$ 1.94M	$ -22.13M	$ -130.10M	$ -149.53M
Total Liabilities	$ 397.95M	$ 381.56M	$ 364.98M	$ 192.38M	$ 352.93M
Stockholders Equity	$ 248.67M	$ 269.08M	$ 78.60M	$ 141.10M	$ 142.06M
Cash Flow	-
Free Cash Flow	$ -21.62M	-	$ -17.40M	$ -33.81M	-
Operating Cash Flow	$ -16.62M	$ -18.22M	$ -2.33M	$ -33.77M	-
Investing Cash Flow	$ -2.00M	$ -182.76M	$ 35.55M	$ 42.02M	-
Financing Cash Flow	$ 1.78M	$ 207.13M	$ 114.71M	$ 12.99M	-

Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

Income Statement >

Mirum Pharmaceuticals Debt to Assets

Balance Sheet >

Mirum Pharmaceuticals Cash Flow

Cash Flow >

Mirum Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing